Drug resistance to targeted therapeutic strategies in non-small cell lung cancer

W Liu, Y Du, R Wen, M Yang, J Xu - Pharmacology & therapeutics, 2020 - Elsevier
Rapidly developing molecular biology techniques have been employed to identify cancer
driver genes in specimens from patients with non-small cell lung cancer (NSCLC). Inhibitors …
被引用次数：166 相关文章

Drug resistance to targeted therapeutic strategies in non-small cell lung cancer

WJ Liu, Y Du, R Wen, M Yang… - Pharmacology & …, 2020 - pubmed.ncbi.nlm.nih.gov
Rapidly developing molecular biology techniques have been employed to identify cancer
driver genes in specimens from patients with non-small cell lung cancer (NSCLC). Inhibitors …

[引用][C] Drug resistance to targeted therapeutic strategies in non-small cell lung cancer

W Liu, Y Du, R Wen, M Yang, J Xu - Pharmacology & Therapeutics, 2020 - cir.nii.ac.jp
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Drug resistance to targeted therapeutic strategies in non-small cell lung cancer.

WJ Liu, Y Du, R Wen, M Yang, J Xu - Pharmacology & Therapeutics, 2019 - europepmc.org
Rapidly developing molecular biology techniques have been employed to identify cancer
driver genes in specimens from patients with non-small cell lung cancer (NSCLC). Inhibitors …